JSM 2004 Online Program

JSM Activity #12

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page


Legend: = Applied Session, = Theme Session, = Presenter FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center		Add To My Program
12	Sun, 8/8/04, 2:00 PM - 3:50 PM	TCC-718 A
Phase 2/3 Combination Designs to Accelerate Drug Development - Topic Contributed - Papers
Biopharmaceutical Section
Organizer(s): Liu Qing, J&J Pharmaceutical Research and Development
Chair(s): Pilar Lim, J&J Pharmaceutical Research Development
2:05 PM	Issues with Phase II/III Combination Designs — H.M. James Hung, U.S. Food and Drug Administration
2:25 PM	Phase 2/3 Combination Designs Comparing Several with a Control — Qing Liu, J&J Pharmaceutical Research and Development
2:45 PM	Optimized Two-stage Adaptive Design — Keaven M. Anderson, Merck & Co., Inc.; Qing Liu, J&J Pharmaceutical Research and Development
3:05 PM	Nonstop Drug Development: Strategies for a Quick Transition from Phase II to Phase III — Ronald W. Helms, Rho, Inc.; Karen Kesler, Rho, Inc.
3:25 PM	Disc: Allan R. Sampson, University of Pittsburgh
3:45 PM	Floor Discussion